PTC Therapeutics
PTCT
#3037
Rank
C$7.55 B
Marketcap
C$90.57
Share price
0.08%
Change (1 day)
0.17%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$4.85 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are C$4.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$4.25 B5.68%
2024-12-31C$4.02 B11.73%
2023-12-31C$3.60 B29.25%
2022-12-31C$2.78 B12.86%
2021-12-31C$2.46 B12.13%
2020-12-31C$2.20 B63.71%
2019-12-31C$1.34 B28.44%
2018-12-31C$1.04 B253.99%
2017-12-31C$0.29 B46.94%
2016-12-31C$0.20 B4.17%
2015-12-31C$0.19 B379.08%
2014-12-31C$40.32 M146.63%
2013-12-31C$16.35 M-49.04%
2012-12-31C$32.08 M-88.84%
2011-12-31C$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
C$113.87 B 2,244.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$10.20 B 110.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.31 B-93.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.36 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.15 B-96.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$0.38 B-92.11%๐Ÿ‡บ๐Ÿ‡ธ USA